CLASS II ONGOING Device recall · Reported 4 Dec 2024 · FDA Enforcement Report

Vitros Chemistry Products CRP Slides- In vitro diagnostic recalled

Ortho-Clinical Diagnostics is recalling Vitros Chemistry Products CRP Slides- In vitro diagnostic quantitatively measures, distributed nationwide in the US. The recall was initiated on 11 Oct 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/GTIN 10758750000296 Coating 1221, expiration date 10/01/2024 Coating 1222, expiration date 01/01/2025
Quantity recalled7717 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0535-2025
FDA event ID
95634
Recalling firm
Ortho-Clinical Diagnostics, Rochester, NY
Classification
Class II
Status
Ongoing
Recall initiated
11 Oct 2024
FDA classified
25 Nov 2024
Reported
4 Dec 2024
Type
Voluntary: Firm initiated
Reason category
Other Reasons

Timeline

11 Oct 2024Recall initiated by company
25 Nov 2024Classified by FDA+45 days
4 Dec 2024Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

May Generate Negatively Biased Results When Testing Samples with High Concentrations of CRP, showing less than upper AMI of 90 mg/L (in the 70-90 mg/L range) while the samples having higher than 90 mg/L. User no way to know if the sample has to be diluted to measure again.

Product as listed by the FDA

VITROS Chemistry Products CRP Slides- In vitro diagnostic quantitatively measures C-reactive protein (CRP) concentration in serum and plasma Model/Catalog Number: 1926740

Where it was distributed

Worldwide - US Nationwide distribution in the states of AZ, FL, ID, IL, KS, MN, MT, NY, PA, UT and the countries of Australia, Belgium, Bermuda, Brazil, Canada L3R 0B8, Chile, China, Colombia, Denmark, France, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore 609917, Spain, Sweden, The Netherlands, United Kingdom.

Nationwide ArizonaFloridaIdahoIllinoisKansasMinnesotaMontanaNew YorkPennsylvaniaUtah

Questions about this recall

Why was it recalled?

May Generate Negatively Biased Results When Testing Samples with High Concentrations of CRP, showing less than upper AMI of 90 mg/L (in the 70-90 mg/L range) while the samples having higher than 90 mg/L. User no way to know if the sample has to be diluted to measure again.

Which lots are affected?

UDI/GTIN 10758750000296 Coating 1221, expiration date 10/01/2024 Coating 1222, expiration date 01/01/2025

Where was it sold?

Worldwide - US Nationwide distribution in the states of AZ, FL, ID, IL, KS, MN, MT, NY, PA, UT and the countries of Australia, Belgium, Bermuda, Brazil, Canada L3R 0B8, Chile, China, Colombia, Denmark, France, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore 609917, Spain, Sweden, The Netherlands, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ortho-Clinical Diagnostics

All 311

Other Test Kits & Diagnostics recalls

All 2,656